#MinorityHealthMonth spotlights the FDA's commitment to health equity through biosimilars, making essential meds more accessible. Discover how these treatments can enhance patient care for all communities.👉 Learn more and access resources: bit.ly/43ocXsT

Check out the latest FDA Roundup, our at-a-glance summary of agency updates: fda.gov/news-events/pr…

Today, we published the FDA Voices: A Milestone in Facilitating the Development of Safe and Effective Biosimilars. fda.gov/news-events/fd…

Also today, we announced that we’ve…

FDA approved the 50th biosimilar and released its revised Biosimilars Action Plan (BAP).

Remember when #biosimilars were supposed to save patients money?
#PBM #PBM Reform #pharmacy #independentpharmacy #drugprices

FDA has approved the 50th biosimilar, reflecting the markedly increased availability of biosimilar products—products that treat a wide range of chronic and severe illnesses, and which have already had an important impact on patient access! #FDAVoices fda.gov/news-events/fd…

Excellent workshop about #Euripid and #biosimilars moderated by Claudia Habl in PPRI Conference

PIANO Digestive Disease Week !
✅Pregnancy IBD: Preliminary Results from Helmsley Global Consensus Conference: May 19 10-11:30
✅WOUND HEALING AFTER EPISIOTOMY AND CESAREAN SECTION AMONG WOMEN WITH IBD
May 20 800-815
✅USE OF BIOSIMILARS TO IFX DURING PREGNANCY IN WOMEN IBD May 20:1230-130

📚NEW course available for Rheumatologists, Ophthalmologists, Dermatologists & Nurses on 'Care Plans with Biosimilars' to enhance treatment of immunological conditions & patient discussions about #biosimilars . Enroll now: bit.ly/3IL6f6M #Medscape

Join ACI @ the 15th Summit on #Biosimilars & Innovator Biologics. Gain practical insights & strategies for overcoming hurdles in the 3 critical pillars applicable of this industry: Legal, Regulatory, & Commercialization.
Save 10% w/ D10-999-GIPM24 #Partner rfr.bz/tl8e31h

Proud supervisor moment Cochrane Skin #EDEN meeting in Paris!

Binh and Heber did a great job presenting their Psoriasis Association funded PhD work on biosimilars and biologic serious infection risk in #psoriasis , generating a lot of interest and thought-provoking questions.

For me it is either Rituximab or cyclophosphamide for primary MN, I stopped using CNI for MN. This study NDT about cost-effectiveness is reassuring and we have effective Rituximab biosimilars. Hans-Joachim Anders
academic.oup.com/ndt/advance-ar…

Looking forward to our #EURIPID session at the 4th #PPRI conference 'How we contribute to improving access to #biosimilars ' on 26/4/24.
Join us in Herrensaal at 1.40pm to hear
JAZMP Gesundheit Österreich Liese Barbier Dorthe Bartels RIZIV Frode Hellesnes

Biosimilars 102: Interchangeability, Extrapolation, and Immunogenicity -- A Regulatory Process Primer. How much do you know about #biosimilars and how they are regulated?
🌐 Developed in partnership with U.S. FDA

➡️ ms.spr.ly/6015YyGJZ

Biosimilars haven’t always yielded lower out-of-pocket costs for patients, study finds.. statnews.com/pharmalot/2024… #pharma #biologics #biosimilars #medicines

Q1 2024 | Samsung Biologics

📸1: Business Highlights
📸2: Biosimilars Pipeline

#samsung #biosimilars

🙏 for the invaluable support in #BiosimilarsLatAm - #Europe2024 , online forum designed to foster the growth of #biosimilars in LatAm, connects industry leaders, experts, and regulators, providing insights into regional opportunities, regulatory trends, and partnership models.

When drug companies complain that costs being taken out of their revenue line don't always make it to patients, they sometimes have a point.

Biosimilars haven’t always yielded lower out-of-pocket costs for patients, study finds statnews.com/pharmalot/2024…

🔬 The #biosimilars market is booming as #healthcare systems around the world seek cost-effective alternatives to expensive #biologics . Gain insights into the #BiosimilarsMarket in our article: bit.ly/4dbFs18

#HealthcareInnovation #CostEffectiveCare #PharmaTrends

Researchers receive NIH grant to help develop gene therapy for HIV
Read more at: tinyurl.com/ye24rzxr
To discover more information about HIV join us at BioL-BioS 2024 via: …biosimilars.peersalleyconferences.com
#HIV #therapy #Biosimilars

How anti-VEGF biosimilars are changing retina care

Biosimilars are reducing costs and increasing access, but in retina they also face unique challenges compared with other medical specialties.
retina-specialist.com/article/how-an…
#retina #retina specialist #antivegf #retina ldisease